CLEVELAND, Jan. 20, 2015 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced participation in the upcoming DIA 18th Annual Workshop in Japan for Clinical Data Management.
Mr. Rob Nichols, DATATRAK General Manager Europe and Vice President Global Corporate Development, will present 'The Changing Role of Clinical Data Management and the Associated Processes When Collecting Data via e-Source' at the Workshop on January 30, 2015 at 11:00am JST.
DATATRAK will also co-exhibit with global partner NTT DATA. Mr. Laurence P. Birch, DATATRAK Chairman and CEO and Mr. Bill Coates, DATATRAK Vice-President Business Development and Strategy and NTT DATA leadership will co-host the booth, presenting the latest enhancements to the DATATRAK ONE® Unified Experience™.
"We're amazed that the industry continues to accept eClinical solutions that require repetitive and error-prone manual practices, including data integration," said Mr. Birch. "Our unified platform not only helps our clients avoid these potential problems, but also delivers groundbreaking enterprise-wide functionality. It's time to challenge the status quo in the eClinical industry."
The Workshop will be held in Tokyo, Japan at KFC Hall with a theme of "Focus on Cool Data" with educational content designed for all levels of professionals, from beginner to expert.
Join DATATRAK Thought Leaders:
Tweet: #eSource expertise to be presented by DATATRAK at upcoming @DIA_Japan #clinicaltrial industry event http://bit.ly/1CE6TJ1
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I - Phase IV drug and device studies in multiple languages throughout the world. DATATRAK is located in Cleveland, Ohio; Bryan, Texas; Cary (RTP), North Carolina, Chicago, Illinois; and London, England. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements
are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on November 13, 2014 announcing its results for the third quarter 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.